Danny Hsu: Fascinating Insight into the Cellular Mechanisms of Statins in APLS
Danny Hsu, President of THANZ, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”Fascinating insight into the cellular mechanisms of statins in APLS.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
By Dominika Marova, Paul Frankenbach, Dr. Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl Lackner, and Nadine Müller Calleja
Antiphospholipid antibodies (aPLs) drive thrombosis and inflammation via endothelial protein C-receptor (EPCR)–mediated binding of lysobisphosphatidic acid (LBPA).
Statins may exert direct anti-APS effects through molecular competition at EPCR–lipid interfaces, not merely via lipid-lowering or pleiotropic vascular actions.”
Read the full article here.
Article: Simvastatin competitively inhibits cellular signaling of lipid-binding antiphospholipid antibodies
Authors: Dominika Marova, Paul Frankenbach, Anne Hollerbach, Susanne Strand, Wolfram Ruf, Karl J. Lackner, Nadine Müller-Calleja
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 4, 2026, 13:42David Lloyd: Thanks Lisa Murphy for Your Leadership
-
Feb 4, 2026, 13:21Aleksandar Sič: Happy to Have 2 Abstracts Published in Stroke
-
Feb 4, 2026, 12:44Donovan Sandoval: Honored to Serve as President of Strides for Strokes
-
Feb 4, 2026, 12:34Owen McCarty: Our Recent Study on The Pathogenic Effects of Anthrax Infection
-
Feb 4, 2026, 12:16Amy Goundry: Introducing Blood and Plasma
-
Feb 4, 2026, 11:14Abdul Mannan: 216 Free Flashcards for One of the Toughest Chapters in Haematology
-
Feb 4, 2026, 11:06Eric Boilard։ How Platelets Can Promote Disease in Autoantibody-Mediated Inflammatory Conditions
-
Feb 4, 2026, 09:14Casper Falster: Big News for Anyone Managing Pulmonary Embolism
-
Feb 4, 2026, 09:06Wolfgang Miesbach: Adenoassociated Virus-Based Gene Therapy for Haemophilia